Peter Attia· MD
you know part of the problem was when the science policy makers were looking at this they went so heavy on the innovation and they wound up producing a lot of really cool vaccines that are highly effective but in terms of durability for scale up to make 4 billion doses i don't think that was high enough on their radar screen and didn't realize that when you use a brand new technology it's really hard to move to 4 billion doses